- Social:
Georgetown University Medical Center
Adjunct professor of Neurology at Georgetown University Medical Center and chief of its Neuroethics Studies Program
PROFILE
James Giordano
Guest
FROM James Giordano
To the Point
Smart Drugs: The Quest for Getting an Edge Let's face it, who doesn't want to be sharper, more alert, and able to ace anything you want to do without having to get much sleep? Now, in addition to Ritalin and Adderall, there's a new crop of over-the-counter drugs aimed at enhancing brain function, including Provigil and Modafinil. Originally a narcolepsy drug Modafanil – or Moda -- is easy to obtain on college campuses now. Entrepreneurs, video gamers, office workers and musicians are taking it to give them an edge in a competitive world. But is it safe? Is this the beginning of a medicalized level doping of our minds? Are smart drugs miracle pills, pathways to addiction or just plain cheating?
Recommended
To the Point
Ex-FBI Director Comey tells his side of the story Today, former FBI Director James Comey came close to calling the President who fired him a liar. The White House denied the claim and called it insulting, but Republican Senators did not challenge Comey’s truthfulness. Many questions remain: did the President try to obstruct a federal investigation? Later, we’ll go behind the “velvet rope” for a look at 5-Star health care for the richest Americans.
Left, Right & Center
President Trump: US to withdraw from the Paris Climate Accord Trump says he was elected to serve Pittsburgh, not Paris.
To the Point
Janesville and the American Dream Janesville, Wisconsin is the hometown of Republican House Speaker Paul Ryan. But he couldn’t prevent the closing of the General Motors factory after 100 years. On this Memorial Day rebroadcast of To the Point, we hear what’s happened to what once was a model of American middle-class unity.
To the Point
Who's to blame for the opioid crisis? Some of the lawyers who took on Big Tobacco are now going after Big Pharma. It’s all about the deadly epidemic of opioid use. Are the drug companies to blame? What about the users? Later, on today’s Talking Point: making sense of Britain’s upset election.